go to contents go to side menu go to main menu

main menu area

main menu area

Innovative University Changing the World through Convergence

Embed to SNS

Research News

Scientists Sniff Out How Amyloid β Contributes to Loss of Smell in Alzheimer’s Disease

  • 조회. 1512
  • 등록일. 2021.02.09
  • 작성자. External Relations Team

New study shows that uneven accumulation of amyloid β is linked to olfactory dysfunction or partial loss of smell, an early symptom of Alzheimer’s disease 

Olfactory dysfunction or partial loss of smell is one of the earliest symptoms of Alzheimer’s disease (AD). While accumulation of the toxic amyloid β protein in the brain is known to drive AD progression, its involvement with olfactory sensory neurons is poorly understood. Researchers have now dug deeper into the molecular mechanisms underlying olfactory dysfunction by assessing behavioral, physiological, and anatomical changes in a mouse model of AD. These findings could help reveal therapeutic targets for AD.  


(왼쪽부터) DGIST 뇌‧인지과학전공 문제일 교수, 손고운 석박통합과정생

Prof. Cheil Moon with his Ph.D student Gowoon Son presenting their data 
on olfactory dysfunction in Alzheimer’s disease in their neurobiology lab
Photo courtesy: DGIST 


Loss of smell or olfactory dysfunction is an early indication of the neurodegenerative Alzheimer’s disease (AD) and appears in approximately 90% of all patients. While loss of smell is a major symptom, patients with AD are only unable to recognize specific odors and do not completely lose their sense of smell; this suggests a possible region-specific involvement of the olfactive center in the brain. Amyloid β (Aβ), a toxic protein that accumulates in the brain is a known contributing factor in AD pathogenesis and is also present in the olfactory system that controls the sense of smell. However, the pathology and mechanisms of AD-specific olfactory dysfunction involving olfactory sensory neurons (OSNs) remain unclear.

To address this gap, a group of researchers from DGIST, Korea, led by Professor Cheil Moon, probed deeper to understand the neuronal mechanisms underlying olfactory dysfunction in AD.  Talking about their latest study, which was recently published in Alzheimer’s Research and Therapy, Prof. Moon states, “We have been particularly interested in the region-specific degeneration of sensory neurons in the olfactory system during AD progression. In our new study, we investigate the association between physiology and olfactory behavior using an AD mouse model to understand the involvement of olfactory neurons in disease pathogenesis”

In this study, the researchers used a mutant mouse model expressing high levels of Aβ and exhibiting nervous system deficits that simulate AD pathology. They tested whether the mice were able to locate hidden food based on smell and where they could identify and differentiate various odors. They found that the mice required a much longer time to seek food and exhibited partial olfactory dysfunction. They further confirmed this physiologically by using a calcium-based sensor: they found that the mice were receptive to certain odors but could not identify others owing to neuronal deficits in specific areas of the olfactory system.

Interestingly, when they dug deeper, they found that the Aβ protein was unevenly distributed across different anatomical regions of the olfactory system. Furthermore, the regions that expressed higher levels of Aβ were, in fact, those regions that exhibited lower activation of OSNs and lower odor detection. This highlights the role of region-specific Aβ accumulation in olfactory dysfunction.

In addition, the researchers also identified anatomical defects and a lower neuron turnover indicative of lesser proliferation and higher neuron death rate in specific olfactory regions including the olfactory epithelium and bulb that likely contribute to the loss of smell. 

Prof. Moon concludes by stating the long-term implications of their work. He remarks, “Partial loss of smell can be a potential diagnostic strategy for the early screening of persons at risk of developing AD. The findings of our study enhance the understanding of the association between AD progression and Aβ accumulation in the olfactory system that can further reveal interesting therapeutic targets.”



For more information, contact:
Cheil Moon, Professor
Department of Brain and Cognitive Sciences,
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
E-mail: cmoon@dgist.ac.kr

Associated Links
Research Paper in the journal of Scientific Reports
DOI : 10.1186/s13195-020-00730-2 

Journal Reference
Gowoon Son, Seung-Jun Yoo, Shinwoo Kang, Ameer Rasheed, Da Hae Jung, Hyunjun Park, Bongki Cho, Harry W. M. Steinbusch, Keun-A Chang, Yoo-Hun Suh & Cheil Moon, "Region-specific amyloid-β accumulation in the olfactory system influences olfactory sensory neuronal dysfunction in 5xFAD mice", Alzheimer’s Research & Therapy, online Published on January 4th, 2021.


DGIST Scholar Researcher Page Banner(Eng)_2